scholarly journals Alcohol marketing versus public health: David and Goliath?

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Mary Madden ◽  
Jim McCambridge
Keyword(s):  
Public Health ◽  
Global Health ◽  
World Health Organisation ◽  
Global Strategy ◽  
World Health ◽  
Health Improvement ◽  
Alcohol Policies ◽  
Alcohol Marketing ◽  
The World ◽  
David And Goliath

Abstract Background Alcohol harms are rising globally, and alcohol policies, where they exist, are weak or under-developed. Limited progress has been made since the formulation of the World Health Organisation (WHO) Global Strategy in 2010. WHO is seeking to accelerate progress in implementing international efforts to reduce the harmful use of alcohol. The threat to global health posed by tobacco is well understood by policy communities and populations globally; by contrast alcohol is much less so, despite available evidence. The competition for epistemic authority Global alcohol corporations have sought to become trusted sources of advice for policy makers and consumers, while continuing to grow their markets. Evidence-informed public health messaging faces formidable competition from transnational corporations as the worlds of corporate and political communications, social and mainstream media become increasingly linked, presenting new opportunities for corporate actors to shape global health governance. Alcohol messaging that uses means of persuasion tied to industry agendas does not tell a clear story about commercial determinants of health, and does not contribute to health improvement. On the contrary, the basic tenets of an evidence-informed population-based approach are denied and the policy measures supported by high quality evidence are being opposed, because they are inimical to commercial interests. A David and Goliath metaphor for this state of affairs, which seems to fit at first glance, may unwittingly reinforce the status quo. Conclusion Public opinion on alcohol and policy issues varies across time and place and can be influenced by dedicated public health interventions. Alcohol marketing dominates people’s thinking about alcohol because we currently allow this to happen. Greater ambition is needed in developing countermarketing and other interventions to promote evidence-informed ideas with the public. Alcohol policies need to be further developed, and implemented more widely, in order to arrest the growing burden of alcohol harms across the world.

scholarly journals Modelling and analysis of COVID-19 epidemic in India

2020 ◽  
Author(s):  
Alok Tiwari
Keyword(s):  
Public Health ◽  
Doubling Time ◽  
Single Case ◽  
World Health Organisation ◽  
Public Health Emergency ◽  
Positive Case ◽  
World Health ◽  
The Public ◽  
First Case ◽  
The World

ABSTRACTCOVID-19 epidemic is declared as the public health emergency of international concern by the World Health Organisation in the second week of March 2020. This disease originated from China in December 2019 has already caused havoc around the world, including India. The first case in India was reported on 30th January 2020, with the cases crossing 6000 on the day paper was written. Complete lockdown of the nation for 21 days and immediate isolation of infected cases are the proactive steps taken by the authorities. For a better understanding of the evolution of COVID-19 in the country, Susceptible-Infectious-Quarantined-Recovered (SIQR) model is used in this paper. It is predicted that actual infectious population is ten times the reported positive case (quarantined) in the country. Also, a single case can infect 1.55 more individuals of the population. Epidemic doubling time is estimated to be around 4.1 days. All indicators are compared with Brazil and Italy as well. SIQR model has also predicted that India will see the peak with 22,000 active cases during the last week of April followed by reduction in active cases. It may take complete July for India to get over with COVID-19.

COVID-19: Avoiding a second tragedy in a tuberculosis burdened country

2020 ◽  
Vol 90 (2) ◽  
Author(s):  
Siddharth Raj Yadav ◽  
Rohit Kumar ◽  
Nitesh Gupta ◽  
Pranav Ish ◽  
Shibdas Chakrabarti ◽  
...  
Keyword(s):  
Public Health ◽  
Human Immunodeficiency Virus ◽  
The Elderly ◽  
World Health Organisation ◽  
Public Health Emergency ◽  
World Health ◽  
Special Population ◽  
Global Public Health ◽  
Immunodeficiency Virus ◽  
The World

To the EditorNovel Coronavirus disease (COVID-19) was first notified in December 2019 from Wuhan, China. Now, it has spread rapidly and has been declared a pandemic affecting over 200 countries with widespread morbidity and mortality. It has been postulated that the most vulnerable population are the elderly, people living in crowded areas, children and immune-compromised individuals, such as people living with human immunodeficiency virus (HIV). The correlation of tuberculosis (TB), HIV and malnutrition are well documented and hence, people with tuberculosis should be considered as special population in this pandemic. TB is an ancient disease among humans recorded as far back as seventy thousand years which was declared a global public health emergency in 1993 by the World Health Organisation (WHO). India has the highest TB burden in the world.

Participation in the World Health Organization

2020 ◽  
Vol 17 (1) ◽  
pp. 261-290 ◽  
Author(s):  
Steven A. Solomon ◽  
Claudia Nannini
Keyword(s):  
Public Health ◽  
Global Health ◽  
World Health Organization ◽  
Regional Level ◽  
World Health ◽  
Global Public Health ◽  
The World ◽  
Health Organization ◽  
Collaborative Efforts

Participation in the World Health Organization (WHO) is a multifaceted matter and should be understood as not only referring to the governance of WHO, but also to its scientific and technical work as well as its collaborative efforts towards advancing global public health more generally. The article is concerned, in particular, with the legal and political framework surrounding attendance and participation of states and various entities in the governing bodies of the Organization, at the global and regional level. It shows that participation in the governance of WHO is still today a domain reserved to the determination of its Member States. At the same time, solutions have been found and continued efforts are necessary to take into account geopolitical considerations and to ensure a meaningful and inclusive participation of all relevant actors in global health discussions.

scholarly journals Max Wilson and the Principles and Practice of Screening for Disease

2020 ◽  
Vol 6 (1) ◽  
pp. 15
Author(s):  
Kate Hall
Keyword(s):  
Public Health ◽  
International Society ◽  
Neonatal Screening ◽  
World Health Organisation ◽  
Population Screening ◽  
World Health ◽  
The World ◽  
The Hague ◽  
Opening Session

The name Wilson will be forever associated with co-author Jungner and ten principles of population screening published in 1968 by the World Health Organisation (WHO) as Public Health Papers No 34. These principles have since been used, modified or extended throughout much of Europe and beyond. Very little was known about Dr. J.M.G. Wilson and his life and how he came to write this monograph until the Silver Jubilee meeting of the International Society for Neonatal Screening held in The Hague in 2016. The opening session was chosen to be ‘The Wilson and Jungner criteria for screening for disease’.

scholarly journals What Will it Take to Address the Global Threat of Antibiotic Resistance?

2015 ◽  
Vol 43 (2) ◽  
pp. 363-368 ◽  
Author(s):  
Steven J. Hoffman ◽  
Kevin Outterson
Keyword(s):  
Public Health ◽  
Antibiotic Resistance ◽  
Collective Action ◽  
Global Health ◽  
Global Strategy ◽  
World Today ◽  
The World ◽  
The Many ◽  
Global Threat ◽  
Economic Tools

Of the many global health challenges facing the world today, only a small number require global collective action. Most health challenges can be fully addressed through action at local, regional or national levels.What kind of actions must be taken to address the global threat of antibiotic resistance (ABR)? What legal, political and economic tools might be needed to achieve this level of action?In March 2015 the Dag Hammarskjöld Foundation convened a workshop in Uppsala, Sweden to address these questions in partnership with the Global Strategy Lab, the Journal of Law, Medicine & Ethics (JLME), the Norwegian Institute of Public Health, and ReAct — Action on Antibiotic Resistance. Eleven concise articles were commissioned to explore whether ABR depended on global collective action, and if so, what tools could help states and non-state actors to achieve it.

scholarly journals SARS: current overview, aetiology and epidemiology

2003 ◽  
Vol 3 (2) ◽  
pp. 46-55
Author(s):  
Semra Čavaljuga ◽  
Michael Faulde ◽  
Jerrold J. Scharninghausen
Keyword(s):  
Public Health ◽  
World Health Organisation ◽  
The United States ◽  
Air Travel ◽  
World Health ◽  
New Disease ◽  
The Past ◽  
Health Authorities ◽  
The World ◽  
Public Health Authorities

At this moment, public health authorities, physicians and scientists around the world are struggling to cope with a severe and rapidly spreading new disease in humans called severe acute respiratory syndrome, or SARS. According to World Health Organisation (WHO) this appears to be the first severe and easily transmissible new disease to emerge in the 21st century. Though much about the disease remains poorly understood, including the details of the causative virus, we do know that it has features that allow it to spread rapidly along international air travel routes. As of 10 May 2003, a cumulative 7296 probable SARS cases with 526 deaths have been reported from 30 countries on three continents (WHO, ProMED). In the past week, more than 1000 new probable cases and 96 deaths were reported globally. This represents an increase of 119 new cases and 8 new deaths compared with 9 May 2003 (China (85), Taiwan (23), and Hong Kong (7) represented the overwhelming majority, with one additional case each reported from France, Malaysia, Singapore, and the United States). Only in China, as of 10 May 2003 (WHO) total of 4884 with 235 deaths have been reported. Some outbreaks have reassuring features.

scholarly journals Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation

2020 ◽  
Vol 4 ◽  
pp. 35
Author(s):  
Marlee Tichenor ◽  
Devi Sridhar
Keyword(s):  
Global Health ◽  
World Bank ◽  
Burden Of Disease ◽  
Historical Context ◽  
World Health Organisation ◽  
World Health ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
The World Bank ◽  
The World

The global burden of disease study—which has been affiliated with the World Bank and the World Health Organisation (WHO) and is now housed in the Institute for Health Metrics and Evaluation (IHME)—has become a very important tool to global health governance since it was first published in the 1993 World Development Report. In this article, based on literature review of primary and secondary sources as well as field notes from public events, we present first a summary of the origins and evolution of the GBD over the past 25 years. We then analyse two illustrative examples of estimates and the ways in which they gloss over the assumptions and knowledge gaps in their production, highlighting the importance of historical context by country and by disease in the quality of health data. Finally, we delve into the question of the end users of these estimates and the tensions that lie at the heart of producing estimates of local, national, and global burdens of disease. These tensions bring to light the different institutional ethics and motivations of IHME, WHO, and the World Bank, and they draw our attention to the importance of estimate methodologies in representing problems and their solutions in global health. With the rise in the investment in and the power of global health estimates, the question of representing global health problems becomes ever more entangled in decisions made about how to adjust reported numbers and to evolving statistical science. Ultimately, more work needs to be done to create evidence that is relevant and meaningful on country and district levels, which means shifting resources and support for quantitative—and qualitative—data production, analysis, and synthesis to countries that are the targeted beneficiaries of such global health estimates.

scholarly journals Metric partnerships: global burden of disease estimates within the World Bank, the World Health Organisation and the Institute for Health Metrics and Evaluation

2019 ◽  
Vol 4 ◽  
pp. 35 ◽  
Author(s):  
Marlee Tichenor ◽  
Devi Sridhar
Keyword(s):  
Global Health ◽  
World Bank ◽  
Burden Of Disease ◽  
Historical Context ◽  
World Health Organisation ◽  
World Health ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
The World Bank ◽  
The World

The global burden of disease study—which has been affiliated with the World Bank and the World Health Organisation (WHO) and is now housed in the Institute for Health Metrics and Evaluation (IHME)—has become a very important tool to global health governance since it was first published in the 1993 World Development Report. In this article, based on literature review of primary and secondary sources as well as field notes from public events, we present first a summary of the origins and evolution of the GBD over the past 25 years. We then analyse two illustrative examples of estimates and the ways in which they gloss over the assumptions and knowledge gaps in their production, highlighting the importance of historical context by country and by disease in the quality of health data. Finally, we delve into the question of the end users of these estimates and the tensions that lie at the heart of producing estimates of local, national, and global burdens of disease. These tensions bring to light the different institutional ethics and motivations of IHME, WHO, and the World Bank, and they draw our attention to the importance of estimate methodologies in representing problems and their solutions in global health. With the rise in the investment in and the power of global health estimates, the question of representing global health problems becomes ever more entangled in decisions made about how to adjust reported numbers and to evolving statistical science. Ultimately, more work needs to be done to create evidence that is relevant and meaningful on country and district levels, which means shifting resources and support for quantitative—and qualitative—data production, analysis, and synthesis to countries that are the targeted beneficiaries of such global health estimates.

scholarly journals Smallpox in the Post-Eradication Era

Viruses ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 138 ◽  
Author(s):  
Hermann Meyer ◽  
Rosina Ehmann ◽  
Geoffrey L. Smith
Keyword(s):  
Public Health ◽  
Human Population ◽  
Health Benefit ◽  
World Health Organisation ◽  
World Health ◽  
Viral Spread ◽  
The World ◽  
The Usa ◽  
The Impact

Widespread vaccination programmes led to the global eradication of smallpox, which was certified by the World Health Organisation (WHO), and, since 1978, there has been no case of smallpox anywhere in the world. However, the viable variola virus (VARV), the causative agent of smallpox, is still kept in two maximum security laboratories in Russia and the USA. Despite the eradication of the disease smallpox, clandestine stocks of VARV may exist. In a rapidly changing world, the impact of an intentional VARV release in the human population would nowadays result in a public health emergency of global concern: vaccination programmes were abolished, the percentage of immunosuppressed individuals in the human population is higher, and an increased intercontinental air travel allows for the rapid viral spread of diseases around the world. The WHO has authorised the temporary retention of VARV to enable essential research for public health benefit to take place. This work aims to develop diagnostic tests, antiviral drugs, and safer vaccines. Advances in synthetic biology have made it possible to produce infectious poxvirus particles from chemicals in vitro so that it is now possible to reconstruct VARV. The status of smallpox in the post-eradication era is reviewed.

The Content and Efficacy of Environmental Public Health Journal Homepages

2000 ◽  
Vol 12 (1) ◽  
pp. 32-36 ◽  
Author(s):  
Elaine S. Lindars ◽  
Jeff T. Spickett
Keyword(s):  
Public Health ◽  
World Health Organisation ◽  
World Health ◽  
Environmental Health Sciences ◽  
Environmental Public Health ◽  
The Us ◽  
The World ◽  
Public Money ◽  
Health Journal ◽  
High Degree

The information on several environmental public health journal homepages has been assessed for its quality and quantity, using selected key criteria. These criteria included the extent of text available, the ability to search the website, the table of contents free via email, and the presence of hyper-links. A high degree of variability is seen, with services and facilities offered ranging from none to the entire journal available for no fee. The journal homepages that are the most comprehensive are those that are associated with major institutions and hence financed by contributions from their members or public money, i.e. the British Medical Association, the World Health Organisation and the US National Institute of Environmental Health Sciences. The journal homepages associated with these institutions offered full text of both current and archived issues as well as additions such as the ability to search other sites, web links, and in some cases hyper-linked references and information on related articles. The provision of text on the Internet should be an essential aim for all journal Homepages, to ensure fast and effective conveyance of information to health professionals. Asia Pac J Public Health 2000;12(1): 32-36

Sign in / Sign up

Export Citation Format

Share Document